NCT01209026View on ClinicalTrials.gov

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

PHASE1CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

June 23, 2010

Primary Completion Date

January 4, 2011

Study Completion Date

January 4, 2011

Conditions
Asthma
Interventions
DRUG

Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination

Novel dry powder inhaler

DRUG

Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination

Novel dry powder inhaler

DRUG

Placebo Inhaler

Matching placebo Novel dry powder inhaler. Lactose monohydrate and magnesium stearate.

DRUG

Moxifloxacin 400mg

Film coated oral tablet

DRUG

Moxifloxacin placebo

Film coated oral tablet

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY